Q-omics provides the consensus-scored MIR4307HG profile across patient tissues and cancer cell-line models. MIR4307HG expression is associated with patient survival in 9 of 34 cancer types, with the highest sampling consensus in SKCM. Among the 18 cancer types available for tumor–normal comparison, MIR4307HG is differentially expressed in 7, with the highest sampling consensus in READ. Additionally, MIR4307HG RNA expression shows 6,376 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight SKCM, READ, and TGCT as cancer lineages where MIR4307HG shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR4307HG — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR4307HG survival associations across molecular data types. MIR4307HG RNA expression shows survival associations in the most cancer types (9). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR4307HG RNA expression–survival associations across cancer types. High MIR4307HG expression shows unfavorable associations in THCA, DLBC, STAD and KIRC, but favorable associations in SKCM and KIRP. The SKCM Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .001). Together, the overview and detailed table identify SKCM as the clearest survival context for MIR4307HG RNA expression.
This table summarizes MIR4307HG tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 7. The strongest signals are observed in READ for RNA.
This table ranks reproducible tumor–normal expression differences for MIR4307HG. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR4307HG shows lower tumor expression in READ and KIRC and higher tumor expression in LUSC, KIRP, LUAD and LIHC. The READ box plot shows higher MIR4307HG RNA expression in normal versus tumor tissue (log2 FC = −0.132, t-test p = .003).
This table shows molecular features associated with MIR4307HG in patient tissues and cancer cell lines. In patient samples, MIR4307HG shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
